High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

(2022) Pascal Benkert et al.   LANCET NEUROLOGY

Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome

(2022) Eva-Maria Wendel et al.   Multiple Sclerosis Journal

MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis

(2021) Mattia Rosso et al.   JOURNAL OF NEUROIMAGING

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

(2021) Patrick Schindler et al.   Journal of Neuroinflammation

Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies

(2021) Xuechun Chang et al.   Frontiers in Immunology

Serum neurofilament light chain in adult and pediatric patients with myelin oligodendrocyte glycoprotein antibody‐associated disease: Correlation with relapses and seizures

(2021) Wenjing Luo et al.   JOURNAL OF NEUROCHEMISTRY

High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics

(2021) Allysa Lui et al.   Multiple Sclerosis and Related Disorders

Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes

(2021) Marta Simone et al.   Frontiers in Neurology

Blood neurofilament light levels segregate treatment effects in multiple sclerosis

(2020) Bénédicte Delcoigne et al.   NEUROLOGY

International multicenter examination of MOG antibody assays

(2020) Markus Reindl et al.   Neurology-Neuroimmunology & Neuroinflammation

Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis

(2020) Mattia Rosso et al.   Annals of Clinical and Translational Neurology

Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease

(2020) Hyunjin Kim et al.   Neurology-Neuroimmunology & Neuroinflammation

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis

(2020) Marie-Christine Reinert et al.   Neurology-Neuroimmunology & Neuroinflammation

Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders

(2019) Sara Mariotto et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical trials of disease-modifying agents in pediatric MS

(2019) Emmanuelle Waubant et al.   NEUROLOGY

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

(2019) Patrick Waters et al.   JAMA Neurology

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis

(2019) Jens Kuhle et al.   Multiple Sclerosis Journal

High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome

(2018) Roos M van der Vuurst de Vries et al.   Multiple Sclerosis Journal

High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome

(2018) Roos M van der Vuurst de Vries et al.   Multiple Sclerosis Journal

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

(2017) Lenka Novakova et al.   NEUROLOGY

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis

(2009) Mark P. Gorman et al.   ARCHIVES OF NEUROLOGY